| Financial Year |
March 31 2023 |
| Monetary Funds |
2,615,024,264.85 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
195,954,760.27 |
| Accounts Receivable |
9,973,798,372.08 |
| Advances to Suppliers |
445,398,530.59 |
| Other Receivables |
96,945,284.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
27,140,944.43 |
| Dividend Receivable |
-- |
| Inventories |
2,697,828,129.84 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,506,473.00 |
| Total Current Assets |
16,421,324,203.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,611,241.27 |
| Investment Properties |
243,899.30 |
| Fixed Assetes |
973,300,679.46 |
| Under-construction Projects |
1,684,681.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,827,991.57 |
| R&D expenses |
-- |
| Goodwill |
765,460,157.17 |
| Long-Term Deferred and Prepaid Expenses |
69,189,409.92 |
| Deferred Income Tax Assets |
61,138,506.75 |
| Other Non-Current Assets |
128,209,751.34 |
| Sub-Total of Non-Current Assets |
2,484,195,654.48 |
| Total Assets |
18,905,519,858.13 |
| Short-Term Loans |
3,334,567,139.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,352,095,071.61 |
| Accounts Payable |
2,991,923,852.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,738,861.42 |
| Taxes Payable |
76,858,277.83 |
| Interest Payable |
8,077,161.42 |
| Dividend Payable |
-- |
| Other payables |
939,378,169.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,794,287.38 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
10,800,337,762.25 |
| Long-term Loans |
305,500,000.00 |
| Bonds Payable |
721,943,669.04 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,160,114.22 |
| Other Non-Current Liabilities |
231,456,372.46 |
| Sub-Total of Non-Current Liabilities |
1,482,304,369.03 |
| Total Liabilities |
12,282,642,131.28 |
| Paid-In Capital(Or Share Stock) |
362,228,313.00 |
| Capital Surplus |
1,980,498,521.68 |
| Surplus Reserve |
266,716,186.12 |
| LESS:Treasury Stock |
41,791,781.28 |
| Undistributed Profits |
3,496,760,162.64 |
| Minority Stockholder's Interest |
405,617,083.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,217,260,643.27 |
| Owner's Equity（Stockholder's Equity） |
6,622,877,726.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,905,519,858.13 |
